Basel, Basel, Switzerland
I am an open minded enthusiastic leader working >20 years in the CDMO industry - I am driven by science and technology to help to bring new medicines to patients.
The Siegfried Group is a global life sciences company, headquartered in Switzerland, with facilities located in Switzerland, the USA, Malta, China, Germany and France. In 2017, the company achieved net sales of CHF 750.5 million and currently employs approximately 2300 people. Siegfried Holding AG is publicly listed on the Swiss Stock Exchange in Zurich (SIX: SFZN). Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe with major markets include – USA, India, Russia & CIS countries, and Europe. www.drreddys.com
Speedel Pharma AG was acquired by Novartis AG in 2008 for USD 900M. Speedel Pharma AG developed drugs (focus on renin inhibitors such as Tekturna (Aliskiren)) for the treatment of cardiovascular and metabolic diseases. Tekturna is the first in a new class of drugs called direct renin inhibitors, which target an enzyme responsible for triggering a process that can contribute to high blood pressure. The company was founded in 1998 and is based in Basel, Switzerland.